1. Home
  2. BOLD vs CYN Comparison

BOLD vs CYN Comparison

Compare BOLD & CYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • CYN
  • Stock Information
  • Founded
  • BOLD 2018
  • CYN 2013
  • Country
  • BOLD United States
  • CYN United States
  • Employees
  • BOLD N/A
  • CYN N/A
  • Industry
  • BOLD
  • CYN EDP Services
  • Sector
  • BOLD
  • CYN Technology
  • Exchange
  • BOLD Nasdaq
  • CYN Nasdaq
  • Market Cap
  • BOLD 24.4M
  • CYN 28.0M
  • IPO Year
  • BOLD 2024
  • CYN 2021
  • Fundamental
  • Price
  • BOLD $1.17
  • CYN $5.97
  • Analyst Decision
  • BOLD Buy
  • CYN
  • Analyst Count
  • BOLD 4
  • CYN 0
  • Target Price
  • BOLD $4.00
  • CYN N/A
  • AVG Volume (30 Days)
  • BOLD 80.0K
  • CYN 425.1K
  • Earning Date
  • BOLD 08-05-2025
  • CYN 08-06-2025
  • Dividend Yield
  • BOLD N/A
  • CYN N/A
  • EPS Growth
  • BOLD N/A
  • CYN N/A
  • EPS
  • BOLD N/A
  • CYN N/A
  • Revenue
  • BOLD N/A
  • CYN $434,837.00
  • Revenue This Year
  • BOLD N/A
  • CYN $1,162.03
  • Revenue Next Year
  • BOLD N/A
  • CYN $427.83
  • P/E Ratio
  • BOLD N/A
  • CYN N/A
  • Revenue Growth
  • BOLD N/A
  • CYN 445.29
  • 52 Week Low
  • BOLD $1.00
  • CYN $3.62
  • 52 Week High
  • BOLD $4.72
  • CYN $1,312.50
  • Technical
  • Relative Strength Index (RSI)
  • BOLD 51.81
  • CYN 40.49
  • Support Level
  • BOLD $1.09
  • CYN $4.96
  • Resistance Level
  • BOLD $1.19
  • CYN $6.76
  • Average True Range (ATR)
  • BOLD 0.05
  • CYN 0.50
  • MACD
  • BOLD -0.00
  • CYN -0.06
  • Stochastic Oscillator
  • BOLD 82.76
  • CYN 39.00

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About CYN Cyngn Inc.

Cyngn Inc is an industrial autonomous vehicle technology company. Its flagship innovation is DriveMod, an autonomous driving solution that can be flexibly deployed on multiple vehicle types manufactured by Original Equipment Manufacturers in various environments.

Share on Social Networks: